323 related articles for article (PubMed ID: 20954805)
21. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.
Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I
FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908
[TBL] [Abstract][Full Text] [Related]
22. A regenerative approach to the treatment of multiple sclerosis.
Deshmukh VA; Tardif V; Lyssiotis CA; Green CC; Kerman B; Kim HJ; Padmanabhan K; Swoboda JG; Ahmad I; Kondo T; Gage FH; Theofilopoulos AN; Lawson BR; Schultz PG; Lairson LL
Nature; 2013 Oct; 502(7471):327-332. PubMed ID: 24107995
[TBL] [Abstract][Full Text] [Related]
23. Oligodendrocyte Progenitor Cells Directly Utilize Lactate for Promoting Cell Cycling and Differentiation.
Ichihara Y; Doi T; Ryu Y; Nagao M; Sawada Y; Ogata T
J Cell Physiol; 2017 May; 232(5):986-995. PubMed ID: 27861886
[TBL] [Abstract][Full Text] [Related]
24. A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.
Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
BMC Res Notes; 2016 Sep; 9(1):419. PubMed ID: 27592856
[TBL] [Abstract][Full Text] [Related]
25. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
Kremer D; Küry P; Dutta R
Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
[TBL] [Abstract][Full Text] [Related]
26. A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
Li C; Xiao L; Liu X; Yang W; Shen W; Hu C; Yang G; He C
Glia; 2013 May; 61(5):732-49. PubMed ID: 23440860
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice.
Cristofanilli M; Harris VK; Zigelbaum A; Goossens AM; Lu A; Rosenthal H; Sadiq SA
Stem Cells Dev; 2011 Dec; 20(12):2065-76. PubMed ID: 21299379
[TBL] [Abstract][Full Text] [Related]
28. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis?
Maier O; van der Heide T; van Dam AM; Baron W; de Vries H; Hoekstra D
Mol Cell Neurosci; 2005 Feb; 28(2):390-401. PubMed ID: 15691718
[TBL] [Abstract][Full Text] [Related]
29. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
Franco PG; Silvestroff L; Soto EF; Pasquini JM
Exp Neurol; 2008 Aug; 212(2):458-67. PubMed ID: 18572165
[TBL] [Abstract][Full Text] [Related]
30. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
31. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
32. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination.
Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H
J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413
[TBL] [Abstract][Full Text] [Related]
33. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
34. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.
Medina-Rodríguez EM; Bribián A; Boyd A; Palomo V; Pastor J; Lagares A; Gil C; Martínez A; Williams A; de Castro F
Sci Rep; 2017 Mar; 7():43545. PubMed ID: 28256546
[TBL] [Abstract][Full Text] [Related]
35. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?
Franklin RJ; Blakemore WF
Mult Scler; 1997 Apr; 3(2):84-7. PubMed ID: 9291159
[TBL] [Abstract][Full Text] [Related]
36. The fatty acid binding protein FABP7 is required for optimal oligodendrocyte differentiation during myelination but not during remyelination.
Foerster S; Guzman de la Fuente A; Kagawa Y; Bartels T; Owada Y; Franklin RJM
Glia; 2020 Jul; 68(7):1410-1420. PubMed ID: 32017258
[TBL] [Abstract][Full Text] [Related]
37. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
38. Transcription factor 7 like 2 promotes oligodendrocyte differentiation and remyelination.
Weng C; Ding M; Fan S; Cao Q; Lu Z
Mol Med Rep; 2017 Aug; 16(2):1864-1870. PubMed ID: 28656232
[TBL] [Abstract][Full Text] [Related]
39. Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
Preisner A; Albrecht S; Cui QL; Hucke S; Ghelman J; Hartmann C; Taketo MM; Antel J; Klotz L; Kuhlmann T
Acta Neuropathol; 2015 Aug; 130(2):247-61. PubMed ID: 25943886
[TBL] [Abstract][Full Text] [Related]
40. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
